SCHEMBL31565825

SCHEMBL31565825

N#CCC(=O)NCC(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ DPP4 P27487 3/20 0.39
▸ DPP8 Q6V1X1 2/20 0.39
▸ GHSR Q92847 1/20 0.39
▸ LIPE Q05469 1/20 0.39
▸ FAP Q12884 1/20 0.39
▸ DPP7 Q9UHL4 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ S1PR1 P21453 2/20 0.38
▸ PREP P48147 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31566040 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ASCN9A
SCHEMBL31566054 0.85 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ASCN9A
SCHEMBL31565927 0.85 ALDH1A1 (0.45) ALDH1A1L3MBTL1MEN1KMT2ASCN9A
SCHEMBL31565830 0.84 ALDH1A1 (0.47) ALDH1A1L3MBTL1MEN1KMT2ASCN9A
SCHEMBL31565905 0.84 ALDH1A1 (0.45) ALDH1A1L3MBTL1MEN1KMT2ASCN9A
SCHEMBL31566092 0.84 FAP (0.43) KMT2ADPP4DPP8LIPEFAP
SCHEMBL31566066 0.82 GHSR (0.49) ALDH1A1L3MBTL1SCN9AGHSRLIPE
SCHEMBL31565929 0.81 LIPE (0.40) L3MBTL1SCN9ADPP4DPP8GHSR
SCHEMBL31565855 0.81 ALDH1A1 (0.45) ALDH1A1L3MBTL1SCN9AGHSRLIPE
SCHEMBL31565894 0.81 NPC1 (0.44) ALDH1A1L3MBTL1SCN9AGHSRLIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 ALDH1A1 2760/4885L3MBTL1 1076/4885MEN1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback